Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction

被引:35
作者
Bove, K
Neumann, P
Gertzberg, N
Johnson, A
机构
[1] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA
[2] Stratton Vet Affairs Med Ctr, Res Serv, Albany, NY 12208 USA
关键词
antisense; edema; messenger ribonucleic acid; permeability; transcription;
D O I
10.1152/ajplung.2001.280.5.L914
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We tested the hypothesis that endothelial cell nitric oxide synthase (ecNOS) mediates the tumor necrosis factor (TNF)-alpha -induced increase in nitric oxide (NO) and albumin permeability in pulmonary microvessel endothelial monolayers (PEM). PEM lysates were analyzed for ecNOS mRNA (RT-PCR), ecNOS protein (Western immunoblot), NO levels (NO2-, the oxidation product of NO), and barrier function (albumin clearance rate). PEM were incubated with TNF (50 ng/ml) for 0.5, 2, 4, and 24 h. TNF induced a decrease in ecNOS mRNA at 2, 4, and 24 h. TNF induced an acute (0.5 h) increase followed by a protracted decrease (4-24 h) in ecNOS protein levels. The other NOS isotypes, inducible and brain NOS, could not be detected in the PEM using RT-PCR and Western blot assay. ecNOS antisense oligonucleotide decreased ecNOS protein, which prevented the increase in NO and albumin permeability at TNF-4 h. Spermine-NONOATE, the NO agonist, ablated the protective effect of ecNOS antisense oligonucleotide on albumin permeability in response to TNF-4 h. However, ecNOS antisense oligonucleotide had no effect on the TNF-induced increase in albumin permeability at 24 h despite prevention of the increase in NO. The data indicate that the isotype ecNOS mediates generation of NO and the acute (i.e., 4 h) barrier dysfunction; however, the prolonged (i.e., 24 h) increase in the TNF-induced increase in endothelial permeability is independent of NO.
引用
收藏
页码:L914 / L922
页数:9
相关论文
共 44 条
  • [1] PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN
    BEUTLER, B
    MILSARK, IW
    CERAMI, AC
    [J]. SCIENCE, 1985, 229 (4716) : 869 - 871
  • [2] Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells
    Bouloumié, A
    Schini-Kerth, VB
    Busse, R
    [J]. CARDIOVASCULAR RESEARCH, 1999, 41 (03) : 773 - 780
  • [3] Cosentino F, 1998, EUR HEART J, V19, pG3
  • [4] Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
    Dimmeler, S
    Fleming, I
    Fisslthaler, B
    Hermann, C
    Busse, R
    Zeiher, AM
    [J]. NATURE, 1999, 399 (6736) : 601 - 605
  • [5] Bradykinin and changes in microvascular permeability in the hamster cheek pouch: Role of nitric oxide
    Feletou, M
    Bonnardel, E
    Canet, E
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) : 1371 - 1376
  • [6] Feng YY, 1999, INVEST OPHTH VIS SCI, V40, P157
  • [7] The endothelial nitric-oxide synthase-caveolin regulatory cycle
    Feron, O
    Saldana, F
    Michel, JB
    Michel, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) : 3125 - 3128
  • [8] Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α
    Ferro, T
    Neumann, P
    Gertzberg, N
    Clements, R
    Johnson, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (06) : L1107 - L1117
  • [9] Endothelial barrier dysfunction and p42 oxidation induced by TNF-alpha are mediated by nitric oxide
    Ferro, TJ
    Gertzberg, N
    Selden, L
    Neumann, P
    Johnson, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 272 (05) : L979 - L988
  • [10] FERRO TJ, 1996, AM J RESP CRIT CARE, V153, pA637